Welcome to our dedicated page for Amdocs SEC filings (Ticker: DOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Amdocs Limited (NASDAQ: DOX) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer. Amdocs files annual reports on Form 20-F, which include consolidated financial statements, an operating and financial review, and detailed information on its business as a provider of software and services to communications, entertainment, and media service providers. The company also furnishes Form 6-K current reports containing quarterly financial information, earnings press releases, presentations, and proxy materials.
In its filings, Amdocs presents data on revenue, operating income, net income, earnings per share, free cash flow, and backlog, and explains the impact of phasing out certain low-margin, non-core business activities. The company uses both GAAP and non-GAAP financial measures and provides reconciliations, as shown in its Form 6-K for the quarter ended June 30, 2025 and in its fiscal 2025 earnings release furnished as an exhibit to a Form 6-K. These documents also discuss managed services revenue, cloud-related activities, and guidance ranges for future periods.
Amdocs’ SEC submissions include notices and proxy statements related to its annual general meeting of shareholders. In a Form 6-K, the company furnishes a notice of annual general meeting that outlines proposals such as the election of directors, amendments to the employee share purchase plan, approval of an increase in the dividend rate under its quarterly cash dividend program, approval of consolidated financial statements, and ratification of the independent registered public accounting firm. The proxy materials describe voting procedures, quorum requirements, and the use of notice-and-access for distributing proxy information.
Through this page, users can review Amdocs’ Form 20-F annual report for the year ended September 30, 2025, which is furnished as an exhibit to a Form 6-K, along with other Form 6-K reports that incorporate unaudited consolidated financial statements and earnings presentations. AI-powered summaries can help explain key sections of lengthy filings, highlight trends in revenue and profitability, and clarify the structure of Amdocs’ business and capital allocation policies. This makes it easier to interpret the company’s financial disclosures, governance proposals, and other regulatory information contained in its SEC filings.
Amdocs Ltd officer Matthew E. Smith filed an initial ownership report showing a mix of stock options and ordinary shares. He holds options over 2,683 Ordinary Shares at an exercise price of 55.8800 expiring on February 1, 2029, 3,127 shares at 71.9500 expiring on February 1, 2030, and 925 shares at 67.4600 expiring on June 1, 2028. The filing also lists 2,014 Ordinary Shares held directly, including shares subject to outstanding restricted stock awards. The options vest in equal annual installments over four years from their grant dates.
Amdocs Ltd director John Anthony MacDonald filed an initial ownership report showing direct beneficial ownership of 24,189 Ordinary Shares. This total includes Ordinary Shares subject to outstanding restricted stock units, reflecting both currently held shares and equity awards that may vest in the future.
Amdocs Ltd director Robert A. Minicucci has filed an initial ownership report showing his equity stake in the company. The filing lists direct ownership of 304,673 Ordinary Shares and an additional 1,088 Ordinary Shares held indirectly by his spouse. The direct holdings include Ordinary Shares that are subject to outstanding restricted stock awards, indicating a mix of fully vested and restricted equity exposure.
Amdocs Ltd officer Rajat Raheja has filed an initial Form 3 reporting existing equity awards. The filing lists multiple Restricted Stock Unit (RSU) grants tied to Ordinary Shares, with individual awards covering 360, 748, 746, 1,050, 1,399 and 1,560 underlying shares. These RSUs vest on various schedules between Nov 10, 2026 and Nov 14, 2029, and each RSU represents a contingent right to receive one Ordinary Share.
Amdocs Limited reported modest growth for the quarter ended December 31, 2025, with revenue rising 4.1% to $1,155.9 million and operating income up 3.9% to $206.7 million, sustaining a 17.9% operating margin. Net income attributable to Amdocs increased 4.3% to $157.6 million, and diluted earnings per share improved to $1.45 from $1.33, helped by share repurchases reducing the share count.
Managed services remained the core of the business, generating $745.9 million of revenue, while North America contributed 66.2% of total sales, Europe 15.7%, and the rest of the world 18.1%. Operating cash flow jumped to $220.2 million, yielding free cash flow of $188.0 million after $32.2 million of capital expenditures.
The company deployed significant capital: it acquired Matrixx Software for approximately $197 million in cash, repurchased about 1.8 million shares for $146.2 million at an average price of $79.78, and paid $56.7 million in dividends at $0.527 per share. Shareholders later approved an 8% quarterly dividend increase to $0.569 per share, while Amdocs ended the quarter with $247.9 million in cash, $130.0 million drawn on its $500.0 million revolving credit facility, and $650.0 million in Senior Notes outstanding.
FMR LLC and Abigail P. Johnson report beneficial ownership of Amdocs Limited common stock. They disclose beneficial ownership of 12,093,177.13 shares, representing 11.2% of the outstanding common stock as of the event date. FMR LLC has sole voting power over 9,918,389.29 shares and sole dispositive power over 12,093,177.13 shares, while Abigail P. Johnson has sole dispositive power over the same 12,093,177.13 shares but no voting power. The securities are certified as acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Amdocs Limited.
Amdocs Limited announced a planned leadership transition, with longtime executive Shuky Sheffer retiring as President and CEO of Amdocs Management Limited and being succeeded by Shimie Hortig, currently Group President of the Americas Business Group, effective March 31, 2026. The board highlighted Sheffer’s role in steering Amdocs through the pandemic and technology shifts, including its move to cloud-native, AI-enabled offerings. Hortig brings more than two decades of experience at Amdocs across senior corporate, finance, and business leadership roles, including leading its largest Americas region. Amdocs, a NASDAQ-listed provider of software and services to communications and media companies, reported revenue of $4.53 billion in fiscal 2025.
Amdocs Limited reported first quarter fiscal 2026 revenue of $1.16 billion, up 4.1% year over year, or 3.5% in constant currency. GAAP diluted EPS rose to $1.45 from $1.33, while non-GAAP diluted EPS increased to $1.81 from $1.66.
The company highlighted a new multi-year strategic agreement with T-Mobile USA, an expanded multi-year engagement with Vodafone Germany, two new Western European customers, and the closing of the Matrixx Software acquisition. Amdocs also introduced aOS, an agentic operating system for telecommunications aimed at generative AI use cases.
Twelve-month backlog reached $4.25 billion, up about 2.7% from a year earlier, and free cash flow improved to $187.9 million from $78.2 million. For fiscal 2026, Amdocs guides to reported revenue growth of 1.5%-5.5%, constant-currency revenue growth of 1.0%-5.0%, GAAP diluted EPS growth of 10.0%-17.0%, non-GAAP diluted EPS growth of 4.0%-8.0%, and free cash flow of $710-$730 million.
Amdocs Limited held its 2026 Annual General Meeting, where shareholders elected ten directors to serve until the 2027 meeting, with each nominee receiving strong support. All management proposals on the agenda were approved.
Shareholders approved an amendment to the 2023 Employee Share Purchase Plan to add 2,200,000 ordinary shares reserved for issuance. They also increased the quarterly cash dividend rate from $0.527 per share to $0.569 per share.
In addition, shareholders approved the Company’s consolidated financial statements for the fiscal year ended September 30, 2025, and ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending September 30, 2026, authorizing the Audit Committee to set its remuneration.
Pzena Investment Management, LLC, a Delaware investment adviser, filed Amendment No. 1 to a Schedule 13G reporting beneficial ownership of 12,195,663 shares of Amdocs Ltd common stock, representing 11.3% of the class as of the event date. Pzena reports sole power to vote or direct the vote over 9,871,510 shares and sole power to dispose or direct the disposition of 12,195,663 shares, with no shared voting or dispositive power.
The filing states that clients of the investment manager have the right to receive and the ultimate power to direct the receipt of dividends and sale proceeds for the reported securities, and that no single client’s interest relates to more than five percent of the class. Pzena certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Amdocs.